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Abstract: 
 
Based on theoretical evidence, it has been proposed that HIV-1 may encode several 
selenoprotein modules, one of which (overlapping the env gp41-coding region) has highly 
significant sequence similarity to the mammalian selenoprotein glutathione peroxidase (GPx; 
EC 1.11.1.9). The similarity score of the putative HIV-1 viral GPx homolog relative to an 
aligned set of known GPx is 6.3 SD higher than expected for random sequences of similar 
composition. Based on that alignment, a molecular model of the HIV-1 GPx was constructed by 
homology modeling from the bovine GPx crystal structure. Despite extensive truncation relative 
to the cellular GPx gene, the structural core and the geometry of the catalytic triad of 
selenocysteine, glutamine, and tryptophan are well conserved in the viral GPx. All of the 
insertions and deletions predicted by the alignment proved to be structurally feasible. The model 
is energetically favorable, with a computed molecular mechanics strain energy close to that of 
the bovine GPx structure, when normalized on a per-residue basis. However, considering the 
remote homology, this model is intended only to provide a working hypothesis allowing for a 
similar active site and structural core. To validate the theoretical predictions, we cloned the 
hypothetical HIV-1 gene and found it to encode functional GPx activity when expressed as a 
selenoprotein in mammalian cells. In transfected canine kidney cells, the increase in GPx activity 
ranged from 21% to 43% relative to controls (average 30%, n = 9, P < 0.0001), whereas, in 
transfected MCF7 cells, which have low endogenous GPx activity, a near 100% increase was 
observed (average 99%, n = 3, P < 0.05). 
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As various genome projects have continued to expand the number of entries in nucleic acid 
sequence databases, there has been an increasing demand for computational biology and 
computational chemistry methods capable of solving several fundamental problems (1). The 
latter include the prediction of (i) the existence, location and architecture of genes, (ii) the 
functions of the encoded proteins, and, ultimately, (iii) the structures of the encoded proteins. 
Advances in comparative sequence analysis, including methods for the identification of remote 
homologs (1, 2), coupled with advances in protein structure prediction and molecular mechanics 
(3–5), have now brought all of these objectives within reach, at least when there is some degree 
of homology between a novel gene and known examples in databases. The ability to identify 
remote homologs and predict their protein structures is still a major challenge for computational 
chemists and biologists. 
 
The need for such advanced computational methods should not be underestimated, because their 
use can lead to the identification of genes whose existence or function is not obvious and which 
can be missed even after extensive analysis by conventional methods. To illustrate exactly such a 
case, we present here an example involving a complex retroviral genome, that of the HIV type 1 
(HIV-1). In 1994, based on theoretical evidence, Taylor et al. (6) proposed that HIV-1 might 
encode several selenoprotein modules. Subsequently, one of the proposed HIV-1 selenoprotein 
genes, potentially expressed by a ribosomal frameshift from the env coding region (thus named 
env-fs), was demonstrated to have highly significant sequence similarity to the mammalian 
selenoprotein glutathione peroxidase (GPx; EC 1.11.1.9), which contains a catalytic 
selenocysteine (Sec) residue, encoded by the UGA codon in RNA (7). There is no mystery as to 
why this potential gene was not identified earlier, because the UGA codon generally serves as a 
stop signal for protein synthesis, and only rarely as a Sec codon (8); furthermore, like the 
retroviral pol gene, the putative HIV-1 GPx gene lacks a start codon, and thus does not appear to 
be an “open” reading frame. However, it does have a well conserved potential −1 frameshift 
sequence (A AAA) consistent with the established “P-site slippage” mechanism (7, 9). 
 
In the current study, based on a revised multiple sequence alignment (Fig. 1), we have generated 
a full three-dimensional (3-D) protein model of the hypothetical HIV-1 selenium (Se)-dependent 
GPx, refined the structure by using molecular mechanics, and applied various structural and 
energetic criteria to assess the model. This application of homology modeling is a further 
example of an original method for “structural evaluation of distant homology,” previously 
described by Bhat and Taylor (10), that involves evaluation of a proposed homology by 
examining the consistency between the 3-D model based on the sequence alignment and existing 
biochemical or other data relevant to mechanism and structure. However, because of the remote 
homology involved, such models are not expected to be accurate at the atomic level, but instead 
are expected simply to reflect the potential for a similar protein fold and, as in this case, a 
common structural core and active-site geometry. 
 
To validate the predictions of the theoretical studies, we have cloned this hypothetical HIV-1 
gene, expressed it as a selenoprotein in several mammalian cell lines, and assayed for functional 
GPx enzyme activity in the transfected cells. The theoretical analysis was also useful in the 
design of this expression vector, because the structural analysis enabled us to predict where to 
engineer a start codon in the HIV-1 sequence that would correspond to the N terminal of the 
mature bovine GPx protein. 
 
 
Figure 1. Sequence alignment of HIV-1 env-fs sequence vs. Se-dependent GPx. Sequences are single-letter amino 
acid code, with U as the symbol for Sec, encoded by the UGA codon in RNA. GPx sequences are listed by Swiss-
Prot database accession number, after a prefix of either P- (plasma), C- (cellular), or L- (phospholipid 
hydroperoxide), identifying three major families of Se-dependent GPx sequences. The N terminal of mature GPx 
protein begins at the fourth residue in the alignment. Env-fs amino acids identical to one or more of the aligned GPx 
sequences are shown as letters in the “match” line above the alignment; similar residues are indicated by an asterisk. 
Three active-site regions that are adjacent in 3-D space are shown below the alignment, labeled R1–R3. All three 
regions and their essential catalytic amino acids, Sec, Gln, and Trp (U, Q, and W, respectively, shown highlighted in 
bold), are represented in the truncated env-fs sequence. There are three large internal deletions in env-fs relative to 
the GPx sequences (numbered 1–3 in Fig. 2), at the locations indicated by the symbols %, #, and ∼ in the alignment, 
involving 19, 11, and 41 residues, respectively. As computed by using the alignment shown, i.e., omitting the three 
internal GPx regions where there are major deletions in the putative HIV-1 GPx homolog, the total similarity score 
of the env-fs sequence to the aligned GPx sequences is 6.3 SD above the average similarity score computed for 100 
optimally aligned randomly shuffled sequences of identical composition. This significance score rises to 6.7 SD if 
the comparison is made only to the plasma GPx sequences, to which the HIV sequence is most similar overall; 
however, it also has features of the cellular and phospholipid hydroperoxide types of GPx. 
 
Materials and Methods 
 
Sequence Analysis. 
 
The statistical significance of the similarity between the hypothetical HIV-1 env-fs protein 
(putative GPx) as a query sequence and a prealigned set of mammalian GPx sequences was 
assessed by using the BLOCKALIGN program of Zhang et al. (11). This program produces an 
optimal, gapped alignment of a probe sequence against an existing sequence alignment. By 
random shuffling of the query sequence, the average similarity score for optimally aligned 
random sequences of identical composition can be calculated. Briefly, the method involves (i) 
the optimal alignment of the query sequence against the prealigned family (GPx), which also 
yields a similarity score, followed by (ii) repeated random shuffling and realignment of the query 
sequence and (iii) calculation of the average similarity score and SD for optimally aligned 
random sequences of identical composition to the query sequence. The significance of the 
sequence similarity between the query and the given sequence alignment can then be expressed 
as a shuffling statistic (Z score), calculated as the distance of the actual score from the average 
random score, in SD. For the alignment of Fig. 1, the blosum62 amino acid similarity matrix was 
used, with gap creation and gap extension penalties of 6 and 2, respectively; 100 random 
shufflings were used for the significance calculation. Sec residues were treated as Cys for the 
purpose of these calculations, because no amino acid similarity matrix has yet been developed 
that includes Sec; as discussed previously (11), this approximation will lead to a slight 
underestimation of the significance of alignments involving Sec residues in conserved positions. 
 
Molecular Modeling. 
 
The SYBYL program (Tripos Associates, St. Louis) was used to build the putative HIV-1 viral 
GPx homology model, starting from the bovine cellular GPx x-ray crystal structure (12), 
file 1GP1 from the Protein Data Bank (http://www.rcsb.org/pdb). Based on the alignment of 
Fig. 1 (in which the bovine GPx sequence is shown as no. P00435), the model was constructed 
by using the biopolymer protein_loop option of SYBYL, which uses a knowledge-based 
approach to rebuild regions where insertions and deletions are predicted by the alignment. Both 
insertions and deletions were handled by deleting one or more residues on either side of the 
affected region, and then building a new loop that included those residues, plus or minus the 
required number of residues (e.g., for a single residue insertion, delete 2, rebuild 3). The 
resulting model was refined by molecular mechanics energy minimization using the Kollman all-
atom force field as implemented in SYBYL. A notable difference between Cys and Sec residues 
is the increased acidity of the selenol group, which has a pKa around 6, as opposed to 
approximately 7 for the thiol group of Cys. Thus, the Sec residue was modeled as the 
deprotonated Se− species. Force field parameters and partial atomic charges for the Sec residue 
were estimated by analogy to the Kollman parameters for the Cys residue, combined with the 
results of ab initio molecular orbital calculations on Cys, Sec, methyl thiol, and methyl selenol, 
obtained by using the GAUSSIAN 94 program (Gaussian, Pittsburgh, PA). Kollman partial 
charges were assigned to the Sec residue in such a way that the net change from the Cys charges 
was zero, to preserve electrical neutrality (charge conservation). The molecular orbital 
calculations on Cys and Sec indicated that changing S to Se had little effect on the charge on the 
amino acid α-carbon; thus, the partial charges on the Sec backbone atoms, including the α-
carbon, were set to the same values as those for Cys (which are the same for all amino acids in 
this force field). The total charge on the neutral side chain is then 0.016, as calculated by 
Kollman for Cys. Adding a −1 formal charge to the side chain for the ionized state gives a total 
charge for the side chain of −0.984. The partial charges derived from the MP2/6-311 + +G** ab 
initio calculation for the C, two H, and Se atoms of deprotonated methyl selenol (which summed 
to −1.089) were then scaled to sum to the required total (−0.984), resulting in the following 
partial charges: Se, −0.851; βC, −0.293; and βH, 0.08. For comparison, the computed Se− charge 
based on a similar STO-3G calculation would have been −0.706, a significant underestimation of 
the negative charge as calculated by using the higher basis set. van der Waals parameters for Se 
were set to r = 2.29 and ɛ = 0.276 (13). Other parameters and force constants were taken to be 
identical to those for S, except for the following equilibrium values: angle HC CT Se, 110.5°; 
angle CT CT Se, 108.2°; bond CT Se, 1.95 Å (HC and CT are Kollman force field atom types, 
an H and C, respectively). The full set of force field parameters and charges are posted on our 
web site, http://bioinfo.chem.uga.edu/homepage/wtaylor. For the electrostatic potential energy 
term, the default distance-dependent dielectric model was used (i.e., dielectric constant = r, 
where r is the distance in angstroms between nuclei). A ΔE of 0.001 kcal/mol was used as the 
termination criterion in the final energy minimization. 
 
The model was initially minimized by using a set of distance constraints to maintain the 
geometry of the three residues involved in the catalytic triad, Sec (U), Gln (Q), and Trp (W). In 
previous computer simulations of various GPx active-site intermediates modeled from the bovine 
GPx crystal structure, the Q and W residues were shown to act as H-bond donors to the ionized 
Se atom (14). Thus, the interatomic distances from the Se atom to the Trp N1 (3.5 Å), from Se to 
the Gln amide N (3.4 Å), and between the Gln and Trp nitrogens (3.9 Å) were constrained for the 
first round of energy minimization, after which the constraints were removed for the final 
minimization of the model. For comparison, a monomer from the bovine GPx structure was 
minimized similarly but without constraints. 
 
 
Construction of HIV-1 GPx Eukaryotic Expression Vector. 
 
Because the hypothetical HIV-1 GPx protein encoded by env-fs is predicted to be expressed by a 
−1 frameshift (6, 7), the primary gene product would be an env gp120-GPx fusion protein, with 
an expected molecular mass of about 130 kDa. The GPx homology region is the C-terminal 89 
amino acids of that predicted fusion product, in which form it might function as a minor env 
glycoprotein isoform on the outer membrane surface of virions or infected cells (11). However, a 
potential HIV-1 protease site was predicted immediately upstream of the GPx homology region 
(6, 7), so the GPx module may also be cleaved and released as an independent small (9 kDa) 
protein, functioning inside the cell and possibly in the HIV-1 virion. It is this low molecular mass 
isoform of the putative HIV-1 GPx protein that we have cloned, incorporating a Met start codon 
immediately before the Gly residue that is at the N-terminal end of env-fs in the GPx alignment 
shown in Fig. 1. The DNA fragment corresponding to the putative HIV-1 GPx homolog was 
PCR amplified from the env gp41-coding region of the pBH10 clone of HIV-1, obtained from 
the National Institutes of Health AIDS Research and Reference Reagent Program, Rockville, 
MD. The PCR primers used for the HIV-1 env-GPx fragment were: 5′ sense, 5′-
TTTGCTAGCATGGGAAGCAGCAGGAAGCACTATG-3′, containing an NheI site, and 3′ 
reverse complement 5′-GCAAGCTTCTAGCATTCCAAAGCACAGC-3′, containing a HindIII 
site. Note that in the first primer listed above the required ATG start codon has been incorporated 
just before the start of the coding sequence (GGAAGC … ). 
 
The established mechanism of Sec insertion in eukaryotic selenoproteins involves an RNA stem-
loop structure called a selenocysteine insertion sequence (SECIS) element in the 3′-untranslated 
region (3′-UTR) of the mRNA. Via a looping back interaction with the ribosome, the SECIS 
element facilitates the decoding of in-frame UGA codons in the upstream coding region as Sec 
(8). Incorporation of a segment of the 3′-UTR spanning the SECIS element of a known 
eukaryotic selenoprotein has been shown to be sufficient for Sec incorporation in heterologous 
selenoprotein genes, and even in peptides encoded by synthetic oligonucleotides with in-frame 
UGA codons (15, 16). Because the mechanisms and location of downstream RNA structure 
elements that HIV may use for recoding the UGA stop codon as a sense codon for Sec are still 
unknown (11), the putative HIV-1 GPx expression construct was designed to include the SECIS 
element of the rat 5′-deiodinase (5′-DI) gene (15), to ensure the translation of the upstream in-
frame UGA codon of the HIV-1 env-fs peptide as Sec during expression in mammalian cells. A 
region of the 3′-UTR of the rat type I 5′-DI gene was PCR amplified from pCDM8-G21, 
provided by Marla Berry, Harvard Medical School, Boston, MA. The PCR primers used for the 
5′-DI SECIS were: 5′ sense, 5′-GCAAGCTTCGAGTAACTCTGTTCCACTG-3′, containing 
a HindIII site, and 3′ reverse complement, 5′-CCGGATCCCGGATTATAATCGTTAGC-3′, 
containing a BamHI site. 
 
To generate the eukaryotic expression vector pGD, the HIV-1 env-GPx and 5′-DI SECIS 
fragments were subcloned into the pEGFP-C1 vector (CLONTECH), by using the following 
cloning sites: NheI, HindIII (GPx) and HindIII, BamHI (SECIS). The sequence of the entire 
transcribed region of the resultant plasmid pGD was verified by DNA sequencing. Sequencing 
and oligonucleotide syntheses were performed at the University of Georgia Molecular Genetics 
Instrumentation Facility. Restriction enzymes were obtained from Promega; other chemicals 
were obtained from Sigma unless otherwise specified. 
 
Cell Culture and Transfection. 
 
The MCF-7 human breast cell line was obtained from the American Type Culture Collection 
(Manassas, VA). The MDCK (canine kidney) cell line was a gift from Fengxiang Gao, Centers 
for Disease Control and Prevention, Atlanta, GA. Both cell types were grown under 5% CO2 at 
37°C, in DMEM/F12 medium supplemented with 2 mM L-glutamine, 5 μg/ml each of insulin, 
transferrin, and gentamycin, and 0.5% newborn calf serum (Atlanta Biologicals, Norcross, GA). 
MDCK cells were transiently transfected by using Lipofectamine (GIBCO), on six-well plates, 
with each well seeded with 2.5 × 105 cells and 10 μg of plasmid DNA. After transfection, cells 
were grown in medium containing 20 nM sodium selenite for 72 h and then harvested for the 
GPx activity assay. MCF-7 cells were stably transfected by the same method, with 10 μg of 
plasmid used for 3 × 105 cells. Transfected cells were selected for antibiotic resistance to G418 at 
400 μg/ml, by changing G418-containing medium supplemented with 100 nM sodium selenite 
every 3 days for 21–30 days. Positive clones were pooled and propagated in the same medium 
until confluence and harvested for the GPx activity assay. 
 
GPx Enzyme Activity Assay. 
 
Both transiently transfected MDCK cells and stably transfected MCF-7 cells were harvested and 
resuspended in PBS. Cells were lysed by sonication at 4°C at low power. Cell lysates were 
centrifuged at 25,000 × g for 25 min at 4°C. GPx activity in the supernatant was measured by 
spectrophotometric determination of NADPH utilization (as described in ref. 17), in the presence 
of standardized concentrations of glutathione and t-butyl hydroperoxide as substrates. The 
specific enzymatic activities are presented as means ± SD, in units per mg of protein. 
Concentration was measured by the Lowry method with BSA as the standard. 
 
Results 
 
Alignment and Similarity Assessment of HIV-1 env-fs vs. GPx Sequences. 
 
As detailed previously, the putative viral GPx module is encoded overlapping the HIV-1 env 
gp41-coding region in the −1 reading frame (6, 7); thus the gene was tentatively named env-fs, 
for env frameshift. It contains a single UGA codon (potentially encoding Sec) near the middle of 
a small but highly conserved ORF, lacking a start codon but having a conserved −1 frameshift 
signal near its 5′ end. The translated HIV-1 env-fs sequence contains a common variant of the 
GPx active-site consensus sequence spanning the catalytic Sec, shown as a U in Fig. 1. A strong 
similarity between the entire HIV-1-encoded env-fs sequence and an aligned set of GPx 
sequences has been demonstrated: as previously aligned by Taylor et al. (7), the similarity score 
of this HIV sequence vs. an aligned group of GPx sequences is 5 SD above the average similarity 
score of randomly shuffled sequences of identical composition. We examined alternative 
alignments of the C-terminal region of env-fs to GPx in the light of the bovine GPx crystal 
structure and its active site (12, 14), and identified the viral sequence potentially matching a third 
GPx active-site region with a conserved Trp (W), shown as region 3 (R3) in the revised 
alignment of Fig. 1. Thus, this alignment is different in the C-terminal region from that published 
previously (7). The proposed homology and the alignment shown are strongly supported by the 
fact that the HIV-1 Trp codon in question is highly conserved, being found in over 98% of all 
reported group M (“main”) HIV-1 sequences. Because of the degeneracy of the genetic code, this 
conservation cannot be explained by any known coding or structural features of HIV-1, which 
strongly suggests that this is a functional gene (see ref. 11 for a detailed explanation). 
 
The significance score for the env-fs vs. GPx similarity increases to 6.3 SD based on the revised 
alignment of Fig. 1, which reveals a total of three major internal deletions (of 19, 11, and 41 
residues) in the HIV-1 sequence relative to the mammalian GPx sequences, as well as a 
truncation of 30 residues at the C terminus (not shown). These deletions in env-fs, which 
comprise a total of over 50% of the sequence of the mammalian GPx homologs, lie between or 
downstream of the three conserved active-site regions (YUG, GHQ, and W) in the primary 
sequence. 
 
The putative HIV-1 GPx is most similar to the plasma GPx sequences, having 23 of 89 residues 
(26%) identical to aligned plasma GPx residues in Fig. 1, whereas only 19 of 89 (18%) residues 
are identical to those of the aligned bovine cellular GPx sequence (no. P00435 in Fig. 1). 
 
Molecular Modeling. 
 
To assess the proposed homology in structural terms (10), a 3-D molecular model of the HIV-1 
viral GPx (Fig. 2) was made by homology modeling from the bovine GPx structure (12), based 
on the alignment of Fig. 1. Despite the presence of four major deletions in the HIV primary 
sequence relative to known GPx genes (labeled 1–4 in Fig. 2), modeling of the putative HIV-1 
GPx homolog is structurally feasible, because these deletions lie outside of the active-site 
domain, and several of the internal deletions, despite their large size (up to 41 residues), are 
located in places where their excision permits the backbone to be easily reconnected despite the 
loss of numerous residues. For example, from an examination of deleted region 3 as shown in 
Fig. 2, it can be seen that this domain begins and ends at approximately the same location (a little 
above the active-site W label in the figure), and thus coils back on itself, so that its deletion 
permits the resulting structure to be annealed without disruption of the structural core. A similar 
situation exists for deletion 1, which consists of a helix and part of a β sheet that folds back on 
the helix. The deletion labeled 4 in Fig. 2 is the C-terminal region not included in Fig. 1; this 
deletion involves the loss of an outer strand of the core β sheet, which is thereby reduced from 5 
to 4 strands, along with the C-terminal helix seen at the upper center of Fig. 2, which lies on the 
β sheet in the bovine GPx structure. Despite these major deletions, the truncated GPx homolog 
encoded by HIV-1 includes the structural β sheet core of the enzyme, and the entire active-site 
region including the catalytic triad, the residues of which are located in three separate regions 
(R1-R3 in Fig. 1) of the protein chain that come together in 3-D space to form the active site 
(labeled U, Q, and W in Fig. 2). Significantly, the second and third deletions involve noncatalytic 
regions whose function in the bovine GPx is in multimerization to form GPx tetramers. The 
absence of these domains suggests that the HIV-1 GPx homolog probably does not function as a 
multimer, for which there is a precedent, because the phospholipid hydroperoxide GPx is known 
to act as a monomeric enzyme (18). 
 
 
Figure 2. Stereo view of the aligned protein backbones of the putative HIV-1 GPx homology model (ribbon 
rendition) and the x-ray crystal structure of the bovine GPx monomer (line rendition). The active site is in the lower 
foreground, with the side chains of the catalytic triad (Sec, Gln, and Trp) shown in a ball and stick rendition and 
labeled U, Q, and W, respectively; the Se atom is shown as a dot sphere. The C and N terminals of the HIV-1 
peptide are labeled. The regions labeled by numbers 1–3 correspond to the major internal deletions shown as %, #, 
and ∼ in the sequence alignment of Fig. 1. The region labeled 4 is a C-terminal deletion, not shown in the alignment. 
These four deletions are domains of the bovine GPx that have no equivalent in the highly truncated HIV-1 GPx 
homolog. The deleted regions include a helix involved in dimer formation (no. 2) and another region (no. 3) that is 
involved in dimer and tetramer formation. No. 1 is an internal deletion between the U and the Q. Despite these 
deletions, the structural and catalytic core of the enzyme is conserved in the truncated HIV-1 homolog. 
 
Minimization of the protein model as described in Materials and Methods was readily 
accomplished, by using a simple distant-dependent dielectric model for solvation, rather than 
explicit waters; this approximation was also used in the only major molecular dynamics study of 
GPx published to date (14), and is adequate for our purposes. In the final unconstrained model, 
the critical distances between the Se atom and the 2 H-bonding NH donors were still very close 
to those in the bovine GPx structure (Se to Trp N1, 3.2 vs. 3.5 Å; Se to Gln N, 3.3 vs. 3.4 Å). A 
comparison of the active-site geometry of the fully minimized model vs. the bovine GPx crystal 
structure was made by means of an rms fit of the three heavy (non-H) atoms of the residues of 
the catalytic triad involved in H-bonding (Sec Se, Trp N1, Gln amide N). This fit gave an rms 
value of 0.42 Å, suggesting that the required active-site geometry could be conserved in the 
HIV-1 GPx homolog despite the extensive deletions and low sequence identity (18%) relative to 
the bovine sequence. 
 
Energy minimization of the protein model with the Kollman all-atom force field led to a 
substantially negative molecular mechanics “strain” energy of −1410 kcal/mol for 89 residues 
(−15.8 kcal/mol⋅residue), which on a per-residue basis is reasonably close to, but not quite as 
low as, the value obtained by minimizing the bovine GPx crystal structure with the same 
parameters, −3620 kcal/mol for 185 residues (−19.6 kcal/mol⋅residue). A closer examination of 
the nonbonded energy terms (which are the major contributors to the energy) suggests that the 
volume packing of side chains in the model is not quite as good as that for the crystal structure 
(total van der Waals energy of −2.9 kcal/mol⋅residue for the model vs. −4.0 kcal/mol⋅residue for 
the bovine GPx), but that the electronic stabilization of the structure is almost as good (total 
electrostatic energy of −16.9 kcal/mol⋅residue for the model vs. −18.2 kcal/mol⋅residue for the 
bovine GPx; the total H bond energy is essentially identical, −0.39 vs. −0.40 kcal/mol⋅residue). 
This electrostatic stabilization arises in part because of a favorable distribution of ionizable 
acidic and basic residues that, in the model, participate in a number of salt bridges between 
distant residues, which can potentially stabilize the structure, particularly by anchoring the N and 
C termini of the protein chain. The less favorable van der Waals energy term in the model is 
actually to be expected because of the somewhat arbitrary computer-generated side-chain 
conformations in the models, which can be only partially remedied by manual reorientation. 
 
Cloning, Expression, and Functional Assay of the Putative HIV-1 GPx Homolog. 
 
The expression construct pGD was designed to include the SECIS element of the rat 5′-DI gene, 
to ensure the expression of the HIV-1 env-fs peptide as a selenoprotein in mammalian cells, such 
as the MCF7 and MDCK canine kidney cell lines, which contain all of the necessary cellular 
machinery for selenoprotein expression. The question is, does that expressed peptide encode 
functional GPx enzyme activity, or is it a “nonsense” peptide, the expression of which would 
lead to a decline in cellular GPx activity by competing for limited cellular pools of tRNASec? In 
cells transfected with the pGD construct, we observed a consistent and significant increase in 
GPx activity relative to cells transfected with an “empty” construct, the parent pC1 plasmid 
lacking the env-fs and 5′-DI SECIS inserts. In transiently transfected canine kidney (MDCK) 
cells, an increase in GPx activity ranging from 21% to 43% relative to controls was observed 
(average 30%, n = 9, P < 0.0001), whereas in stably transfected MCF7 cells, which have low 
endogenous GPx activity, a near 100% increase could be demonstrated (average 99%, n = 3, P < 
0.05). However, the absolute increase in GPx activity was greater in MDCK cells, probably 
because MCF7 cells have low levels of tRNASec and/or other cellular factors required for 
selenoprotein synthesis, consistent with their low endogenous GPx activity. The concentration of 
sodium selenite in the medium required for optimal GPx expression was also different in the two 
cell types, being 100 nM in MCF7 cells, as opposed to only 20 nM in MDCK cells. These results 
are detailed in Table 1. 
 
Table 1. GPx activity in cells transfected with HIV-1 construct (pGD) vs. controls transfected 
with “empty” construct (pC1) 
Cells/construct Transfection SeO32−, nM Activity, units/mg protein 
MDCK (n = 9) 
   
pC1 Transient 20 54.3  ± 4.20 
pGD Transient 20 70.8  ± 6.13* 
MCF7 (n = 3) 
   
pC1 Stable 100 4.96  ± 2.26 
pGD Stable 100 9.86  ± 1.30** 
* , P < 0.0001, compared with pC1; ** , P < 0.05, compared with pC1. 
 
Discussion 
 
By means of comparative sequence analysis, molecular modeling, and functional assay of the 
expressed protein, we have assessed the twofold hypothesis that a novel HIV-1 gene, env-fs, is 
encoded in an overlapping reading frame of the env gene, and that the protein it codes for is a 
highly truncated Se-dependent GPx module (6, 7). Although the pairwise identity of the putative 
HIV-1 GPx homolog to individual GPx sequences is very low, by using a sensitive multiple 
sequence comparison method, we have demonstrated a highly significant sequence similarity, 
with a Z score of >6 SD (Fig. 1). Furthermore, the essential sequence elements (residues of the 
GPx catalytic triad) are highly conserved within HIV-1 subtypes, as discussed previously (7, 11). 
 
The proposed homology model is supported by the following factors: 
 
(i) Despite several extensive deletions and truncations, the sequence encoded by HIV-1 includes 
the structural core and the complete catalytic center of the GPx enzyme. 
 
(ii) The deletions are structurally feasible, because the deleted regions project away from the 
active site and in several cases consist of noncatalytic domains involved in dimer and tetramer 
formation. 
 
(iii) The geometry of the GPx active site, e.g., distances between critical active-site atoms and 
residues, is not substantially changed in the model relative to the bovine GPx crystal structure. 
 
(iv) There is no exceptional molecular mechanics strain energy associated with the HIV-1 GPx 
model, which appears to have an energetically favorable distribution of charged residues leading 
to the electronic stabilization of the structure. 
 
Thus, overall, the molecular modeling results suggest that the proposed homology is structurally 
feasible and consistent with the known structural requirements for Se-dependent GPx catalysis 
(14), supporting the hypothesis that the hypothetical HIV-1 gene env-fs encodes a truncated but 
potentially functional Se-dependent GPx homolog. Using a standard enzyme assay, we have 
validated the theoretical results by cloning the putative viral peptide shown as env-fs in Fig. 1, 
and demonstrating that it encodes functional GPx activity when expressed as a selenoprotein in 
mammalian cells. 
 
The significance of these results can best be understood in the context of current knowledge 
regarding the biological roles of Se in the immune system and in the regulation of HIV-1 
transcription. Se is an essential trace mineral that serves as a potent dietary antioxidant, in 
addition to other biological functions. Many of its cellular actions, mediated by selenoproteins 
such as GPx and thioredoxin reductase (TDR), are intimately linked to the redox status of the 
cell, and to the redox regulation of genes that are important for various immune cell functions 
(19). Significantly, oxidative stress has been widely documented in AIDS patients (20, 21), and 
is known to be an activator of HIV-1 replication in vitro (22, 23). In light of those observations, 
and the established redox-related roles of Se and selenoproteins, it is not surprising that Se has 
been found to be of critical importance in HIV-1 infection. Se status has consistently been 
correlated with various indicators of HIV-1 disease progression, and Se deficiency is highly 
correlated with HIV-related mortality (reviewed in refs. 7 and 24; 25–27). 
 
GPx and TDR are two of the most widely distributed selenoproteins, and both have been 
demonstrated to be potent regulators of NF-κB, which is the primary cellular factor involved in 
the regulation of HIV-1 transcription. Remarkably, GPx and TDR appear to have opposed 
functions, i.e., GPx inhibits NF-κB by reducing oxidant tone (23, 28), whereas TDR is involved 
in the reductive activation of an essential Cys residue required for the DNA-binding activity of 
NF-κB (29). Thus, via these known cellular selenoproteins, Se is a potent regulator of both NF-
κB activity and HIV-1 transcription. It is therefore reasonable that HIV-1 could have evolved to 
directly participate in those regulatory processes, by encoding its own selenoprotein. 
 
Finally, it must be noted that our results are inconsistent with the conclusions of a recent study 
by Gladyshev et al. (30), who examined selenoprotein expression in HIV-1-infected and 
uninfected T cells, and concluded that there was no evidence of HIV-encoded selenoproteins. 
However, they did note that in HIV-infected cells there was a decline in levels of cellular 
selenoproteins, and an increase in “low molecular mass” Se compounds. The latter observation is 
of interest, because several potential HIV selenoproteins are predicted to be of low molecular 
mass (7–9 kDa), consistent with what Gladyshev et al. observe in HIV-infected T cells. One such 
product is the 9-kDa isoform of the HIV-1 GPx homolog that we have cloned and found to be 
active in our functional assays reported above. Furthermore, the primary observation of 
Gladyshev et al., that levels of cellular selenoproteins decline in HIV-infected cells, is also 
highly consistent with the predictions of the HIV selenoprotein theory, being expected as a 
consequence of HIV selenoprotein expression (6, 24). 
 
In conclusion, we have presented compelling theoretical and functional evidence that strongly 
suggests that HIV-1 encodes a Se-dependent GPx gene. The fact that this gene remained 
undetected in the HIV-1 sequence for 10 years shows that the identification of genes, even in 
known mRNA sequences, is not always a trivial matter. Our ability to predict the function of the 
encoded protein despite its low similarity and extensive truncation relative to individual GPx 
sequences shows that, even in cases of very distant homology, it is sometimes possible to predict 
protein function from sequence. Because of that remote relationship, particularly when combined 
with the extensive truncation of the HIV-1 GPx homolog relative to the cellular enzyme, we 
emphasize that our model for the 3-D structure of the viral homolog is not expected to be 
accurate at the atomic level. However, the model does help to explain how it is possible for such 
a highly truncated homolog to possess GPx enzyme activity. Its degree of correspondence to the 
actual structure must await verification, pending an experimental structure determination. In that 
regard, we have expressed the Cys mutant of the protein in Escherichia coli, and purified the 
protein to homogeneity for structural and functional studies; significantly, the purified 9-kDa 
protein also has low but measurable GPx enzyme activity, despite the mutation of the Sec residue 
to Cys, necessary for bacterial expression of the protein (unpublished data). 
 
Most significantly, the existence of an HIV-encoded selenoprotein gene represents the basis for a 
novel pathogenic mechanism (involving in part competition with cellular selenoprotein synthesis 
as discussed above) that can help to explain why the effects of HIV-1 infection are exacerbated 
in individuals who are Se deficient (24–27). Our hypotheses regarding the potential roles of viral 
selenoproteins in HIV-1 pathogenesis have been discussed in more detail elsewhere and will not 
be repeated here because of space limitations (6, 7, 11, 24, 31). 
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